Health Condition 1: null- Patients diagnosed with Tuberculosis from the DOTS centre Health Condition 2: A15-A19- Tuberculosis Health Condition 3: A150- Tuberculosis of lung
Conditions
Interventions
Intervention1: Screening and management for Diabetes: Patients with TB will be additionally screened for DM by ANMs and referred to PHC for management
Control Intervention1: Usual course: No additiona
Sponsors
The George Institute for Global Health
Eligibility
Inclusion criteria
Inclusion criteria: Patients with Tuberculosis
Exclusion criteria
Exclusion criteria: a. Individuals below 18 years b. People with intellectual disability that prevents them from comprehending the study principles and requirements
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Development of a complex intervention: including the following 1.1 Clinical decision support systems using available national guidelines for the co-management of TB, diabetes and CVD 1.2 Electronic patient records in order to follow up patients in the community 2. Defining the prevalence of DM and CVD risk in patients with TB. 3. Demonstrating feasibility, acceptability and effectiveness Timepoint: Phase 1 (0-2 months) Development of clinical tools and randomisation. Phase 2 (3-4 months) Recruitment of participants and baseline data collection. Phase 3 (5-16 months) Implementation of the pilot intervention. Phase 4 (17-18 months) End of study data collection. | — |
Secondary
| Measure | Time frame |
|---|---|
| Detailed process evaluationTimepoint: end of the study (January 2018) | — |
Countries
India
Contacts
Public ContactPraveen Devarsetty
The George Institute for Global Health, India
Outcome results
None listed